Amgen Inc (NASDAQ:AMGN)

224.72
Delayed Data
As of Feb 26
 -2.80 / -1.23%
Today’s Change
177.05
Today|||52-Week Range
276.69
-2.26%
Year-to-Date
Radius' (RDUS) Q4 Loss Wider Than Expected, Revenues Beat
Feb 26 / Zacks.com - Paid Partner Content
2 Best Pharma Stocks to Buy Right Now
Feb 23 / MotleyFool.com - Paid Partner Content
Merck Makes Another Move to Beef Up Drug Business
Feb 25 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: REGN's Drug Approval & Pipeline Updates From AMGN, BLUE
Feb 17 / Zacks.com - Paid Partner Content
Why Turning Point Is Turning Heads
Feb 23 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Toyota, PepsiCo, BlackRock, Amgen and Allstate
Feb 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close227.52
Today’s open230.00
Day’s range223.00 - 230.64
Volume218,793
Average volume (3 months)2,513,409
Market cap$129.9B
Data as of 4:09pm ET, 02/26/2021

Growth & Valuation

Earnings growth (last year)-4.37%
Earnings growth (this year)+1.38%
Earnings growth (next 5 years)+6.15%
Revenue growth (last year)+8.53%
P/E ratio18.3
Price/Sales5.37
Price/Book13.82

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-1.39-2.21%
ILMNIllumina Inc-6.44-1.44%
MRNAModerna Inc+6.55+4.41%
BIIBBiogen-4.90-1.77%
Data as of 4:18pm ET, 02/26/2021

Financials

Next reporting dateApril 28, 2021
EPS forecast (this quarter)$4.08
Annual revenue (last year)$25.2B
Annual profit (last year)$7.3B
Net profit margin28.77%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Thousand Oaks, California

Forecasts